Open access · US-GOV via ClinicalTrials.gov Clinical trial

Tirzepatide and Organ-Specific Biological Aging: A Parallel-Design Feasibility Study Using Proteomic Organ Clocks in a Preventive Brain Health Cohort

Authors not listed

Atria Research and Global Health Institute (ARGHI) · 2026

Dysbiosis Human Randomized controlled trial

Abstract

The purpose of this study is to evaluate blood-based measures of organ-specific biological age, with a particular focus on the brain, and to investigate their relationship with established clinical indicators of health and their response to treatment with tirzepatide.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-31 MST

Cite this

APA

Anonymous. (2026). Tirzepatide and Organ-Specific Biological Aging: A Parallel-Design Feasibility Study Using Proteomic Organ Clocks in a Preventive Brain Health Cohort. <em>Atria Research and Global Health Institute (ARGHI)</em>. https://clinicaltrials.gov/study/NCT07906041

Vancouver

Anonymous. Tirzepatide and Organ-Specific Biological Aging: A Parallel-Design Feasibility Study Using Proteomic Organ Clocks in a Preventive Brain Health Cohort. Atria Research and Global Health Institute (ARGHI). 2026.

BibTeX

@misc{anon2026Tirzep, title = {Tirzepatide and Organ-Specific Biological Aging: A Parallel-Design Feasibility Study Using Proteomic Organ Clocks in a Preventive Brain Health Cohort}, author = {Anonymous}, journal = {Atria Research and Global Health Institute (ARGHI)}, year = {2026}, }